↓ Skip to main content

A three‐year follow‐up of ranibizumab treatment of exudative AMD: impact on the outcome of carrying forward the last acuity observation in drop‐outs

Overview of attention for article published in Acta Ophthalmologica (1755375X), March 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
42 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A three‐year follow‐up of ranibizumab treatment of exudative AMD: impact on the outcome of carrying forward the last acuity observation in drop‐outs
Published in
Acta Ophthalmologica (1755375X), March 2013
DOI 10.1111/aos.12091
Pubmed ID
Authors

Christina I. Frennesson, Sven Erik G. Nilsson

Abstract

To analyse a 3-year clinical patient cohort of ranibizumab treatment of exudative age-related macular degeneration (AMD), to investigate the impact on visual outcome of carrying forward the last acuity observation in drop-outs and to explore possible differences between the early and the late phase of the study.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 42 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 17%
Student > Master 7 17%
Student > Bachelor 6 14%
Researcher 4 10%
Professor 2 5%
Other 4 10%
Unknown 12 29%
Readers by discipline Count As %
Medicine and Dentistry 14 33%
Nursing and Health Professions 4 10%
Agricultural and Biological Sciences 3 7%
Biochemistry, Genetics and Molecular Biology 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Other 5 12%
Unknown 12 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2014.
All research outputs
#22,759,452
of 25,374,647 outputs
Outputs from Acta Ophthalmologica (1755375X)
#1,859
of 2,330 outputs
Outputs of similar age
#183,349
of 207,610 outputs
Outputs of similar age from Acta Ophthalmologica (1755375X)
#15
of 22 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,330 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 207,610 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.